O
Owlstone Medical
Biotech & Life Sciences · Milton, United Kingdom · Founded 2004
Non-invasive breath biopsy platform for disease detection MoreLess
Owlstone Medical is a health technology startup that operates in the medical diagnostics market. The company specializes in developing non-invasive diagnostic tests using breath biopsy technology. This technology analyzes volatile organic compounds (VOCs) in a patient's breath to detect diseases such as lung cancer at an early stage. The company's primary clients are healthcare providers and research organizations worldwide.
Owlstone Medical's business model revolves around the development and sale of its breath biopsy products and services. The company offers a range of products for breath biopsy research, including the Breath Biopsy OMNI, an advanced solution for volatile metabolite analysis in breath, and the ReCIVA Breath Sampler, a tool for reliable and reproducible breath sample collection. These products are used in clinical trials and research labs to bring VOC biomarker research in-house.
In addition to selling products, Owlstone Medical also offers services such as OMED Health, a service that helps individuals manage their digestive health through at-home breath testing and professional analysis of exhaled gases. The company generates revenue through the sale of its products and services.
Owlstone Medical is making significant strides in the field of early disease detection, as demonstrated by their latest data on the development of a Breath Biopsy test for early detection of lung cancer. The company's innovative approach to medical diagnostics has the potential to revolutionize the healthcare industry by providing non-invasive, accurate, and early detection of various diseases.
Keywords: Owlstone Medical, Breath Biopsy, Non-Invasive Diagnostics, Lung Cancer Detection, Volatile Organic Compounds, Medical Diagnostics Market, Healthcare Providers, Breath Biopsy OMNI, ReCIVA Breath Sampler, OMED Health.
Company overview
Owlstone Medical company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2004
- Headquarters
- Milton, United Kingdom
- Employees
- 148
- Open positions
- None listed
- Dealroom signal
- 64.0
- Investment activity
- 1 companies · latest Jan 2013
- Capital deployed
- $0
- Preferred round
- CORPORATE SPINOUT
Valuation & funding
Owlstone Medical funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANTOther financing | Oct 2025 | $0 | — | Advanced Research Projects Agency for Health - ARPA-H | ↗ |
| GRANTOther financing | Mar 2025 | $2.3M | — | Cystic Fibrosis Foundation | ↗ |
| SERIES EOther financing | Jan 2025 | $27M | $290M | Horizons Ventures · Aviva · Bill & Melinda Gates Foundation · Ventura Capital | ↗ |
| GRANTOther financing | Apr 2024 | $6.5M | — | Bill & Melinda Gates Foundation | ↗ |
| SERIES DOther financing | Sep 2021 | $58M | $232M | Horizons Ventures | — |
| SERIES BOther financing | Aug 2020 | Aviva | — | ||
| LATE VCOther financing | Oct 2018 | Foxconn Technology Group · Aviva · Ventura Capital · Horizons Ventures | ↗ | ||
| LATE VCOther financing | Mar 2018 | Horizons Ventures · Aviva | ↗ | ||
| LATE VCOther financing | Mar 2017 | Aviva | — | ||
| LATE VCOther financing | Jan 2017 | Undisclosed | ↗ |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $7.1M | 0% | −$21M | -300.9% |
| 2025 | $7.1M | +66.8% | −$21M | -300.9% |
| 2024 | $4.2M | +53.4% | −$21M | -501.9% |
| 2023 | $2.8M | +29.3% | −$21M | -769.8% |
| 2022 | $2.1M | +30% | −$21M | -995% |
| 2021 | $1.6M | -59.8% | −$21M | -1267.7% |
| 2020 | $4.1M | — | −$14M | -343.8% |
Growth signals
Owlstone Medical website traffic
Latest recorded traffic for Owlstone Medical is 9.5K monthly website visits, down 2.1% over the last three months. Owlstone Medical's team declined 12.4% over the past year.
Comparisons
Owlstone Medical compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
Owlstone Medical investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Talent graph
Owlstone Medical's talent
Source: Dealroom Talent Intelligence.
Investors
12 investors on Owlstone Medical's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.
Global footprint
Where Owlstone Medical has talent and traffic
team presence
In the news
Latest news about Owlstone Medical
Recent press, funding announcements, and product moves mentioning Owlstone Medical — open to read from the original sources.
Market sentiment
What the market is saying about Owlstone Medical
An AI-synthesized read of the highest-engagement posts about Owlstone Medical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Owlstone Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.